We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Michael Grant MD

Michael J. Grant MD

Assistant Professor of Medicine, Section of Medical Oncology, Yale University School of Medicine; Medical Oncologist and Hematologist, Yale Cancer Center/ Smilow Waterbury Care Center, New Haven, Connecticut

Dr. Michael Grant is an Assistant Professor of Medicine in the Section of Medical Oncology at Yale University School of Medicine.  He is a practicing Medical Oncologist and Hematologist at Yale Cancer Center/ Smilow Waterbury Care Center with a clinical focus on thoracic and genitourinary malignancies.  Dr. Grant’s current research interests include clinical trials and translational work aimed at understanding the biology of lung cancer, including oncogene-driven non-small cell lung cancer.  Dr. Grant has received an ASCO- Conquer Cancer Foundation Young Investigator Award as well and has completed the Yale Cancer Center T32 Advanced Training Program for Physician Scientists. 

Dr. Grant obtained his undergraduate degree with a dual major in Mathematics and Biology from Dickinson College in Carlisle, Pennsylvania.  He then graduated from the Albert Einstein School of Medicine, where he obtained his MD.  Dr. Grant then completed residency training in Internal Medicine at Duke University Hospital, Duke University School of Medicine where he was awarded the Robert M. Califf, MD Medicine Resident Research Award.

Recent Contributions to PracticeUpdate:

  1. Advice and Importance of Patient Cases for Clinicians
  2. The Value of Patient Cases
  3. Staying Updated on Medical Literature and the Associated Challenges
  4. Resected Non-Small Cell Lung Cancer: How Far to Go With Molecular Testing?
  5. 5 Tips for Staying Updated in Medical Literature
  6. Navigating the New Neoadjuvant Paradigm in Resectable NSCLC
  7. EGFR Exon 20 Insertions: Welcoming the New Treatment Paradigm
  8. Resectable Lung Adenocarcinoma — Yes to Immunotherapy, but When?
  9. Acquired Resistance to Osimertinib in EGFR Mutant NSCLC
  10. Isolated CNS Recurrence After Definitive Therapy for Stage III NSCLC

Most Read This Week

Recently Updated